Ruxolitinib In GvHD

NCT02396628 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped impossibility to recruit in the BAT arm

Conditions

Graft vs Host Disease

Interventions

DRUG: Experimental intervention
DRUG: Standard treatment

Sponsor

Prof. Dr. Nikolas von Bubnoff

Collaborators

[object Object]